Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Virological surveillance of influenza and other respiratory viruses during six consecutive seasons from 2006 to 2012 in Catalonia, Spain.

Antón A, Marcos MA, Torner N, Isanta R, Camps M, Martínez A, Domínguez A, Jané M, Jiménez de Anta MT, Pumarola T.

Clin Microbiol Infect. 2016 Jun;22(6):564.e1-9. doi: 10.1016/j.cmi.2016.02.007. Epub 2016 Mar 2.

2.

Impact of quinolone-resistance acquisition on biofilm production and fitness in Salmonella enterica.

Fàbrega A, Soto SM, Ballesté-Delpierre C, Fernández-Orth D, Jiménez de Anta MT, Vila J.

J Antimicrob Chemother. 2014 Jul;69(7):1815-24. doi: 10.1093/jac/dku078. Epub 2014 Apr 4.

PMID:
24706735
3.

Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.

Alvarez-Martínez MJ, Miró JM, Valls ME, Mas J, de la Bellacasa JP, Sued O, Solé M, Rivas PV, de Lazzari E, Benito N, García F, Agustí C, Wilson PE, Gatell JM, Jiménez de Anta MT, Meshnick SR, Moreno A.

Diagn Microbiol Infect Dis. 2010 Sep;68(1):60-5. doi: 10.1016/j.diagmicrobio.2010.04.007.

PMID:
20727472
4.

Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.

García-de-la-Mària C, Marco F, Armero Y, Soy D, Moreno A, del Río A, Almela M, Cervera C, Ninot S, Falces C, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM; Hospital Clínic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2010 Jul;54(7):2781-6. doi: 10.1128/AAC.01011-09. Epub 2010 Apr 26.

5.

D225G mutation in the hemagglutinin protein found in 3 severe cases of 2009 pandemic influenza A (H1N1) in Spain.

Antón A, Marcos MA, Martínez MJ, Ramón S, Martínez A, Cardeñosa N, Godoy P, Torner N, De Molina P, Isanta R, Jiménez de Anta MT, Pumarola T.

Diagn Microbiol Infect Dis. 2010 Jun;67(2):207-8. doi: 10.1016/j.diagmicrobio.2010.02.002. Epub 2010 Mar 31.

PMID:
20356695
6.

Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant.

Fàbrega A, du Merle L, Le Bouguénec C, Jiménez de Anta MT, Vila J.

PLoS One. 2009 Nov 25;4(11):e8029. doi: 10.1371/journal.pone.0008029.

7.

Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Miró JM, García-de-la-Mària C, Armero Y, Soy D, Moreno A, del Río A, Almela M, Sarasa M, Mestres CA, Gatell JM, Jiménez de Anta MT, Marco F; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2009 Oct;53(10):4172-7. doi: 10.1128/AAC.00051-09. Epub 2009 Jul 20.

8.

Characterization of the enzyme aac(3)-Id in a clinical isolate of Salmonella enterica serovar Haifa causing traveler's diarrhea.

Cabrera R, Ruiz J, Sánchez-Céspedes J, Goñi P, Gómez-Lus R, Jiménez de Anta MT, Gascón J, Vila J.

Enferm Infecc Microbiol Clin. 2009 Oct;27(8):453-6. doi: 10.1016/j.eimc.2008.11.016. Epub 2009 Apr 29.

PMID:
19403206
9.

Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.

Alvarez-Martínez MJ, Moreno A, Miró JM, Valls ME, Rivas PV, de Lazzari E, Sued O, Benito N, Domingo P, Ribera E, Santín M, Sirera G, Segura F, Vidal F, Rodríguez F, Riera M, Cordero ME, Arribas JR, Jiménez de Anta MT, Gatell JM, Wilson PE, Meshnick SR; Spanish PCP Working Group.

Diagn Microbiol Infect Dis. 2008 Sep;62(1):34-43. doi: 10.1016/j.diagmicrobio.2008.04.016. Epub 2008 Jun 12.

PMID:
18554841
10.

Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

Marco F, de la Mària CG, Armero Y, Amat E, Soy D, Moreno A, del Río A, Almela M, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2008 Jul;52(7):2538-43. doi: 10.1128/AAC.00510-07. Epub 2008 Apr 21.

11.

Incidence of respiratory viruses among travelers with a febrile syndrome returning from tropical and subtropical areas.

Camps M, Vilella A, Marcos MA, Letang E, Muñoz J, Salvadó E, González A, Gascón J, Jiménez de Anta MT, Pumarola T.

J Med Virol. 2008 Apr;80(4):711-5. doi: 10.1002/jmv.21086.

PMID:
18297697
12.

Human herpesvirus 7 primary infection in kidney transplant recipients.

Antón A, Cervera C, Pumarola T, Moreno A, Benito N, Linares L, Esteva C, Cofán F, Jiménez de Anta MT, Marcos MA.

Transplantation. 2008 Jan 27;85(2):298-302. doi: 10.1097/TP.0b013e3181601413.

PMID:
18212637
13.

Comparative study of virulence traits of Escherichia coli clinical isolates causing early and late neonatal sepsis.

Soto SM, Bosch J, Jimenez de Anta MT, Vila J.

J Clin Microbiol. 2008 Mar;46(3):1123-5. Epub 2007 Dec 26.

14.

Outbreak of norovirus gastroenteritis among staff at a hospital in Barcelona, Spain, September 2007.

Costas L, Vilella A, Llupià A, Bosch J, Jimenez de Anta MT, Trilla A.

Euro Surveill. 2007 Nov 22;12(11):E071122.5. No abstract available.

15.

Virological diagnosis in community-acquired pneumonia in immunocompromised patients.

Camps Serra M, Cervera C, Pumarola T, Moreno A, Perelló R, Torres A, Jiménez de Anta MT, Marcos MA.

Eur Respir J. 2008 Mar;31(3):618-24. Epub 2007 Oct 24.

16.

Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus.

Miró JM, García-de-la-Mària C, Armero Y, de-Lazzari E, Soy D, Moreno A, del Rio A, Almela M, Mestres CA, Gatell JM, Jiménez-de-Anta MT, Marco F; Hospital Clínic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2007 Jul;51(7):2373-7. Epub 2007 May 7.

17.

The role of viruses in the aetiology of community-acquired pneumonia in adults.

Angeles Marcos M, Camps M, Pumarola T, Antonio Martinez J, Martinez E, Mensa J, Garcia E, Peñarroja G, Dambrava P, Casas I, Jiménez de Anta MT, Torres A.

Antivir Ther. 2006;11(3):351-9.

PMID:
16759052
18.

Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia.

Martínez JA, Soto S, Fabrega A, Almela M, Mensa J, Soriano A, Marco F, Jimenez de Anta MT, Vila J.

J Clin Microbiol. 2006 Apr;44(4):1468-74.

19.
20.

Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.

Horcajada JP, Soto S, Gajewski A, Smithson A, Jiménez de Anta MT, Mensa J, Vila J, Johnson JR.

J Clin Microbiol. 2005 Jun;43(6):2962-4.

21.

A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates.

Ruiz J, Moreno A, Jimenez de Anta MT, Vila J.

Int J Antimicrob Agents. 2005 Jun;25(6):542-5.

PMID:
15876526
22.

Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa.

Ruiz J, Bertran S, Sauca G, Julià A, Vila X, Gómez E, Jiménez de Anta MT, Vila J.

Clin Microbiol Infect. 2005 Jan;11(1):71-3.

23.

Molecular epidemiology of tuberculosis in the Bata and Malabo districts of Equatorial Guinea.

Tudó G, González-Martín J, Obama R, Rodríguez JM, Franco JR, Espasa M, Simarro PP, Escaramis G, Ascaso C, García A, Jiménez De Anta MT.

Int J Tuberc Lung Dis. 2004 Dec;8(12):1458-63.

PMID:
15636492
24.

Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis.

Johnson JR, Kuskowski MA, Gajewski A, Soto S, Horcajada JP, Jimenez de Anta MT, Vila J.

J Infect Dis. 2005 Jan 1;191(1):46-50. Epub 2004 Nov 30.

PMID:
15593002
25.

Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains.

Tavío MM, Vila J, Perilli M, Casañas LT, Maciá L, Amicosante G, Jiménez de Anta MT.

J Med Microbiol. 2004 Nov;53(Pt 11):1119-1122. doi: 10.1099/jmm.0.45613-0.

PMID:
15496390
26.

Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment.

Jiménez-Expósito MJ, Torres G, Baraldés A, Benito N, Marco F, Paré JC, Moreno A, Claramonte X, Mestres CA, Almela M, García de la María C, Pérez N, Schell WA, Corey GR, Perfect J, Jiménez de Anta MT, Gatell JM, Miró JM.

Clin Infect Dis. 2004 Oct 1;39(7):e70-3. Epub 2004 Sep 8.

PMID:
15472836
27.
28.

Mechanism of resistance to several antimicrobial agents in Salmonella Clinical isolates causing traveler's diarrhea.

Cabrera R, Ruiz J, Marco F, Oliveira I, Arroyo M, Aladueña A, Usera MA, Jiménez De Anta MT, Gascón J, Vila J.

Antimicrob Agents Chemother. 2004 Oct;48(10):3934-9.

29.

Salicylate decreases production of AmpC type beta-lactamases and increases susceptibility to beta-lactams in a Morganella morganii clinical isolate.

Tavío MM, Perilli M, Vila J, Becerro P, Casañas L, Amicosante G, Jiménez de Anta MT.

FEMS Microbiol Lett. 2004 Sep 1;238(1):139-44.

30.

Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.

Capilla S, Ruiz J, Goñi P, Castillo J, Rubio MC, Jiménez de Anta MT, Gómez-Lus R, Vila J.

J Antimicrob Chemother. 2004 Jun;53(6):1068-71. Epub 2004 Apr 29.

PMID:
15117921
31.

Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.

Tudó G, González J, Obama R, Rodríguez JM, Franco JR, Espasa M, Simarro PR, Escaramís G, Ascaso C, García A, Jiménez de Anta MT.

Int J Tuberc Lung Dis. 2004 Jan;8(1):15-22.

PMID:
14974741
32.

[Different antibiotic resistance mechanisms associated with integrons in clinical isolates of Salmonella typhimurium].

Gallardo F, Ruiz J, Soto SM, Jimenez de Anta MT, Vila J.

Rev Esp Quimioter. 2003 Dec;16(4):398-402. Spanish.

33.

[Usefulness of risk indexes for the prediction of surgical site infection in patients undergoing neurosurgical procedures].

Vernet E, Adell C, Trilla A, Zaragoza M, Sallés M, Jiménez de Anta MT, Ferrer E, Asenjo MA.

Med Clin (Barc). 2004 Jan 31;122(3):92-5. Spanish.

PMID:
14746697
34.

Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain.

Ruiz J, Navia MM, Casals C, Sierra JM, Jiménez De Anta MT, Vila J.

Clin Microbiol Infect. 2003 Sep;9(9):907-11.

35.

Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).

Marco F, Danés C, Almela M, Jurado A, Mensa J, de la Bellacasa JP, Espasa M, Martínez JA, Jiménez de Anta MT.

Diagn Microbiol Infect Dis. 2003 Aug;46(4):259-64.

PMID:
12944017
36.

In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.

Ruiz J, Marco F, Sierra JM, Aguilar L, Garcia-Mendez E, Mensa J, Jiménez De Anta MT, Vila J.

Int J Antimicrob Agents. 2003 Jul;22(1):73-6.

PMID:
12842332
37.

A nosocomial outbreak of influenza during a period without influenza epidemic activity.

Horcajada JP, Pumarola T, Martínez JA, Tapias G, Bayas JM, de la Prada M, García F, Codina C, Gatell JM, Jiménez de Anta MT.

Eur Respir J. 2003 Feb;21(2):303-7.

38.

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults.

Marcos MA, Jiménez de Anta MT, de la Bellacasa JP, González J, Martínez E, García E, Mensa J, de Roux A, Torres A.

Eur Respir J. 2003 Feb;21(2):209-14.

39.

Mutations in gyrA and parC QRDRs are not relevant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates.

Ribera A, Doménech-Sanchez A, Ruiz J, Benedi VJ, Jimenez de Anta MT, Vila J.

Microb Drug Resist. 2002 Winter;8(4):245-51.

PMID:
12523620
41.

Simultaneous identification of Mycobacterium genus and Mycobacterium tuberculosis complex in clinical samples by 5'-exonuclease fluorogenic PCR.

García-Quintanilla A, González-Martín J, Tudó G, Espasa M, Jiménez de Anta MT.

J Clin Microbiol. 2002 Dec;40(12):4646-51.

42.

Distribution of beta-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different beta-lactam antibiotics.

Danes C, Navia MM, Ruiz J, Marco F, Jurado A, Jimenez de Anta MT, Vila J.

J Antimicrob Chemother. 2002 Aug;50(2):261-4.

PMID:
12161409
43.

Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates.

Vila J, Ribera A, Marco F, Ruiz J, Mensa J, Chaves J, Hernandez G, Jimenez De Anta MT.

J Antimicrob Chemother. 2002 Mar;49(3):471-7.

PMID:
11864947
44.

Prevalence of diarrheagenic Escherichia coli strains detected by PCR in patients with travelers' diarrhea.

Vargas M, Gascón J, Gallardo F, Jimenez De Anta MT, Vila J.

Clin Microbiol Infect. 1998 Feb;4(12):682-688.

45.

In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine.

Ribera A, Jurado A, Ruiz J, Marco F, Del Valle O, Mensa J, Chaves J, Hernández G, Jiménez de Anta MT, Vila J.

Diagn Microbiol Infect Dis. 2002 Feb;42(2):123-8.

PMID:
11858908
46.

Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones.

Ruiz J, Jurado A, Garcia-Méndez E, Marco F, Aguilar L, Jiménez de Anta MT, Vila J.

J Antimicrob Chemother. 2001 Oct;48(4):545-8.

PMID:
11581235
47.

No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis.

Saiz A, Marcos MA, Graus F, Vidal J, Jimenez de Anta MT.

J Neurol. 2001 Jul;248(7):617-8. No abstract available.

PMID:
11518005
48.

Detection of unsuspected cases of nosocomial transmission of tuberculosis by use of a molecular typing method.

Tudó G, González J, Gatell JM, Caylà JA, Martínez E, García A, Navarro M, Soriano E, Jiménez de Anta MT; Tuberculosis Investigation Unit of Barcelona, Spain.

Clin Infect Dis. 2001 Aug 15;33(4):453-9. Epub 2001 Jul 20.

PMID:
11462179
49.

New rapid antigen test for diagnosis of pneumococcal meningitis.

Marcos MA, Martínez E, Almela M, Mensa J, Jiménez de Anta MT.

Lancet. 2001 May 12;357(9267):1499-500.

PMID:
11377604
50.

[Seroprevalence of toxoplasmosis in women of childbearing age, 1992-1999].

Pujol-Riqué M, Quintó L, Danés C, Valls ME, Coll O, Jiménez De Anta MT.

Med Clin (Barc). 2000 Sep 30;115(10):375-6. English, Spanish.

PMID:
11262353

Supplemental Content

Loading ...
Support Center